Health Care/Hospital
PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted fo...
2025-11-20 23:12
1424
Kolmar Korea Named Among TIME's World's Best Companies in Sustainable Growth 2026 for the Second Consecutive Year
Ranked in the Top 7% Among More Than 4,000 Global Corporations, Highlighting
Leadership in Eco-Friendly Innovation and Responsible Growth
SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Kolmar Korea
2025-11-20 21:30
1691
Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer
* The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. * The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has met primary endpoints in its phase 3 cli...
2025-11-20 18:52
1764
Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong
HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Clarity Eye Centre announced the arrival of Johnson & Johnson's next-generation SILK™ Laser Eye Technology, now available to patients inHong Kong. The clinic is the first in the city to widely offer the ELITA™ Femtosecond Laser, the advanced system that po...
2025-11-20 17:34
1216
Smartee Deepens Its Strategy for Central Asia and Russia in 2025
SHANGHAI, Nov. 20, 2025 /PRNewswire/ -- Smartee Denti-Technology is reinforcing its international footprint with a focused strategy inCentral Asia and Russia for 2025, cementing its position as a global leader in clear aligner and digital orthodontic technologies. This year, Smartee showcased it...
2025-11-20 13:53
969
Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum with ~100 Surgeries Now Performed with Multiple Surgeons Nationwide
Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed * Adoption of Remplir™ among Australian urologists is accelerating, with ~100 surgeries conducted by surgeons nationwide. * This promising new applicatio...
2025-11-20 13:52
722
Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs
SHANGHAI and HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune dis...
2025-11-20 10:56
964
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry
WuXi AppTec sets new benchmarks in strategic execution and technological
advancement, further strengthening its ability to support innovators worldwide
as they deliver breakthrough medicines for patients.
SAN ANTONIO, Nov. 20, 2025 /PRNewswire/ -- Frost & Sullivan
2025-11-20 10:00
807
USANA Named No. 1 Dietary Supplements Brand in the Philippines for the 7th Consecutive Year
Euromonitor Recognizes USANA Philippines as the Market Leader from 2019 to 2025 MANILA, Philippines, Nov. 20, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in health and wellness, has once again been recognized as the No. 1 dietary supplements brand inthe Philippines* by Eurom...
2025-11-20 09:16
808
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces results from the ZIRCON-X study which finds that almost half of all patients imaged with TLX250-CDx (Zircaix®[1], 89Zr-DFO-girentuximab) PET/CT[2] wo...
2025-11-20 03:00
1203
NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices
WASHINGTON, Nov. 20, 2025 /PRNewswire/ -- The Standing Committee of CITES, an international body responsible for monitoring trade in animal species, announced the results of its review of animal breeding practices inCambodia, thankingCambodia for providing extensive data and relying on science. T...
2025-11-20 01:33
994
HKUST Commences Preparations for New Medical School
Inaugural Cohort in 2028, Cultivating Clinically Excellent and Technology-Savvy Doctors of the Future HONG KONG, Nov. 19, 2025 /PRNewswire/ -- With the support of the HKSAR Government, TheHong Kong University of Science and Technology (HKUST) has commenced preparations to establish a new medical...
2025-11-19 22:55
725
The Rise of Advanced Maternal Age IVF: BaseCare Medical'-B(2170.HK) AI "Undisturbed Culture" Empowers Intelligent Assisted Reproduction
SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese Society of Reproductive Medicine (CSRM2025), held fromNovember 12th to 15th, indicates that the average treatment age for women undergoing IVF inChina has risen to 33.6 years, h...
2025-11-19 19:50
821
KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at MEDICA 2025
XI'AN, China, Nov. 19, 2025 /PRNewswire/ -- Shanghai Kehua Bio-engineering Co., Ltd. (KHB), a global provider of in-vitro diagnostic (IVD) solutions, is showcasing its latest compact chemiluminescence platform—the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer—at MEDICA 2025, one o...
2025-11-19 17:02
903
Older Singaporeans Support Healthier SG, but Lifestyle Habits Still Lag Behind
* New SMU research reveals critical gaps in preventive health, lifestyle habits, and continuity of care asSingapore transitions into a super-aged society. * Despite strong pro-health policies, everyday adoption - especially among older adults - remains limited. * Bridging this gap requires ...
2025-11-19 12:30
765
Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis
HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, today announced key results from its Phase II clinical trial of LNK01004, a skin restric...
2025-11-19 08:00
1636
HKUST Receives Government's Approval to Establish a New Medical School
Dedicated to Nurturing a New Generation of Doctors Supporting Hong Kong Become a Hub for Medical Innovation HONG KONG, Nov. 18, 2025 /PRNewswire/ -- The establishment of Hong Kong's third medical school at TheHong Kong University of Science and Technology (HKUST) was approved today by the Hong Ko...
2025-11-18 19:57
729
The Medical Stories in the War: the Spirit of Internationalism with Boundless Love
GUIYANG, China, Nov. 18, 2025 /PRNewswire/ -- Tuyunguan Pass in Guizhou province, one of the capital cityGuiyang's important pass – "nine gates, four pavilions, and fourteen passes" – was stationed by thousands of Chinese and international medical workers of the Chinese Red Cross Medical Relief C...
2025-11-18 19:45
805
Vantage Foundation Supports Kechara Soup Kitchen in Community Food Aid Initiative in Kuala Lumpur
KUALA LUMPUR, Malaysia, Nov. 18, 2025 /PRNewswire/ -- Vantage Foundation continued its mission to drive meaningful community impact through a recent collaboration with Kechara Soup Kitchen (KSK), one ofMalaysia's leading non-governmental organisations dedicated to serving the urban, rural poor, ...
2025-11-18 17:05
1276
CRScube acquires Mednet to expand global eClinical capabilities
SEOUL, South Korea and MINNEAPOLIS, Nov. 18, 2025 /PRNewswire/ -- CRScube has announced the successful acquisition of Mednet, marking a key milestone in its global strategic growth and expansion into the North American market. The transaction unites two respected eClinical technology vendors with...
2025-11-18 17:00
938
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 264 media titles]
2026-01-01 10:00
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
